FNDC5 and liver disorder: Moreover, for irisin to be recognized as a significant biomarker in liver diseases, including NAFLD, there is a need for a greater number of clinical studies and the development of accurate and specific laboratory tests that would enable the diagnosis of liver diseases based on changes in irisin concentration.